title: Longitudinal changes of serum insulin concentration and insulin antibody features in persistent insulin autoimmune syndrome (Hirata's disease).
abstract: In a 56-year-old woman with granulomas of gold thioglucose in her hips, who developed insulin autoimmune syndrome, the relationships among the frequency or severity of hypoglycemic attacks, serum insulin (IRI) concentration, and characteristics of insulin antibodies were investigated during the clinical course with steroid treatment and two resection operations for the gold-thioglucose granulomas. When hypoglycemia was severe, the total IRI level was elevated, and Scatchard analysis showed that a high-affinity (k1), low-capacity (b1) population of antibodies had a relatively low affinity constant and very high binding capacity compared with the same population of antibodies in insulin-treated diabetic patients. When the attacks were relieved by steroid treatment and/or granuloma resection operation, the total IRI level was decreased and the high-affinity (k1), low-capacity (b1) population of antibodies showed a higher affinity constant and a lower binding capacity than those during the attacks. This indicated that the antibodies changed their characteristics to release insulin into the serum. The k1/b1 population of insulin antibodies with the lower affinity constant and higher binding capacity may easily release human insulin into the serum, leading to hypoglycemia. The longitudinal change of the k1/b1 population suggests a clonal change of the B cells producing the insulin antibody in insulin autoimmune syndrome.
authors.affiliation: Diabetes Center, Tokyo Women's Medical College, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Eguchi
authors.forename: Y
authors.initials: Y
authors.lastname: Uchigata
authors.forename: K
authors.initials: K
authors.lastname: Yao
authors.forename: H
authors.initials: H
authors.lastname: Yokoyama
authors.forename: Y
authors.initials: Y
authors.lastname: Hirata
authors.forename: Y
authors.initials: Y
authors.lastname: Omori
mesh_terms: D006051:Aurothioglucose / Q000009:adverse effects; D001327:Autoimmune Diseases / Q000097:blood* / Q000276:immunology; D005260:Female; D006099:Granuloma / Q000139:chemically induced; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced / Q000276:immunology; D007328:Insulin / Q000097:blood* / Q000276:immunology; D007330:Insulin Antibodies / Q000097:blood*; D008875:Middle Aged; D013577:Syndrome
chemical_list: D007328:Insulin; D007330:Insulin Antibodies; D006051:Aurothioglucose